Reduction of hair growth

Details Reduction of hair growth Reduction of hair growth

2001-06-27

2008-10-21

Padmanabhan, Sreeni (Department: 1617)

Drug, bio-affecting and body treating compositions

Hair treatment

C514S043000, C514S04400A, C514S443000

Reexamination Certificate

active

07439271

ABSTRACT:
Mammalian hair growth is reduced by applying an inhibitor of telomerase to the skin.

REFERENCES:
patent: 3426137 (1969-02-01), Philpitt et al.
patent: 4039669 (1977-08-01), Beylar et al.
patent: 4139638 (1979-02-01), Neri et al.
patent: 4161540 (1979-07-01), Neri et al.
patent: 4191775 (1980-03-01), Glen
patent: 4269831 (1981-05-01), Ferrari et al.
patent: 4370315 (1983-01-01), Greff et al.
patent: 4439432 (1984-03-01), Peat
patent: 4508714 (1985-04-01), Cecic et al.
patent: 4517175 (1985-05-01), Iwabuchi et al.
patent: 4720489 (1988-01-01), Shander
patent: 4885289 (1989-12-01), Breuer et al.
patent: 4923862 (1990-05-01), Hirota
patent: 4935231 (1990-06-01), Pigiet
patent: 5095007 (1992-03-01), Ahluwalia
patent: 5096911 (1992-03-01), Ahluwalia et al.
patent: 5132293 (1992-07-01), Shander et al.
patent: 5143925 (1992-09-01), Shander et al.
patent: 5189212 (1993-02-01), Ruenitz
patent: 5271942 (1993-12-01), Haverhagen
patent: 5300284 (1994-04-01), Wiechers et al.
patent: 5328686 (1994-07-01), Shander et al.
patent: 5362748 (1994-11-01), Schwen et al.
patent: 5364885 (1994-11-01), Ahluwalia et al.
patent: 5411991 (1995-05-01), Shander et al.
patent: 5444090 (1995-08-01), Ahluwalia et al.
patent: 5455234 (1995-10-01), Ahluwalia et al.
patent: 5468476 (1995-11-01), Ahluwalia et al.
patent: 5474763 (1995-12-01), Shander et al.
patent: 5554608 (1996-09-01), Ahluwalia et al.
patent: 5645825 (1997-07-01), Hillebrand et al.
patent: 5648394 (1997-07-01), Boxall et al.
patent: 5652273 (1997-07-01), Henry et al.
patent: 5674477 (1997-10-01), Ahluwalia
patent: 5728736 (1998-03-01), Shander et al.
patent: 5776442 (1998-07-01), Ahluwalia
patent: 5824665 (1998-10-01), Henry et al.
patent: 5840752 (1998-11-01), Henry et al.
patent: 5908867 (1999-06-01), Henry et al.
patent: 5939458 (1999-08-01), Henry et al.
patent: 5958946 (1999-09-01), Styczynski et al.
patent: 5962466 (1999-10-01), Styczynski et al.
patent: 6017912 (2000-01-01), Bussell
patent: 6020006 (2000-02-01), Styczynski et al.
patent: 6037326 (2000-03-01), Styczynski et al.
patent: 6060471 (2000-05-01), Styczynski et al.
patent: 6093748 (2000-07-01), Ahluwalia et al.
patent: 6110458 (2000-08-01), Freeman et al.
patent: 6121269 (2000-09-01), Henry et al.
patent: 6218435 (2001-04-01), Henry et al.
patent: 6235737 (2001-05-01), Styczynski et al.
patent: 6239170 (2001-05-01), Alhuwalia et al.
patent: 6248751 (2001-06-01), Alhuwalia et al.
patent: 6299865 (2001-10-01), Styczynski et al.
patent: 6368789 (2002-04-01), West et al.
patent: 6479466 (2002-11-01), Redfield et al.
patent: 6702705 (2004-03-01), von Borstel et al.
patent: 6713251 (2004-03-01), Stuyver et al.
patent: 0 413 528 (1991-02-01), None
patent: 0 532 219 (1993-03-01), None
patent: 1 458 349 (1976-12-01), None
patent: 9-113096 (1997-06-01), None
patent: WO 98/02134 (1998-01-01), None
patent: WO 98/23276 (1998-06-01), None
patent: WO 99/19466 (1999-04-01), None
Ueno et al., Biochemistry 39: 5995-6002, 2000, Inhibition of human telomerase by rubromycins: implication of spiroketal system of the compounds as an active moiety.
Kitagawa et al., “Demethylating Reagent 5-Azacytidine Inhibits Telomerase Activity in Human Prostate Cancer Cells through Transcriptional Repression ofhTERT”, Clin. Cancer Res. 6: 2868-2875, Jul. 2000.
Caprio et al., A Novel Inhibitor of Human Telomerase Derived from 10Hindolo[3,2-b]quinoline, Bioorg. Med. Chem. Letters, vol. 10, pp. 2063-2066, 2000.
Szatmari et al., “Modified Telomeric Repeat Amplification Protocol: A Quantitative Radioactive Assay for Telomerase without Using Electrophoresis”, Analytical Biochemistry, vol. 282, pp. 80-88, 2000.
Krupp et al., “Cell proliferation, carcinogenesis and diverse mechanisms of telomerase regulation”, CMLS, Cell. Mol. Life Sci., vol. 57, pp. 464-486, 2000.
Murakami et al., “Inhibition of Telomerase Activity and Cell Proliferation by a Reverse Transcriptase Inhibitor in Gynaecological Cancer Cell Lines”, European Journal of Cancer, vol. 35, No. 6, pp. 1027-1034, 1999.
Naasani et al., “FJ5002: A Potent Telomerase Inhibitor Identified by Exploiting the Disease-oriented Screening Program with COMPARE Analysis”, Cancer Research, vol. 59, pp. 4004-4011, Aug. 15, 1999.
Lee et al., “Improved Inhibitors of Glucosylceramide Synthase”, J. Biol. Chem., vol. 274, pp. 14662-14669, May 21, 1999.
Spinedi et al., “N-Oleoylethanolamine Inhibits Glucosylation of Natural Ceramides in CHP-100 Neuroepithelioma Cells: Possible Implications for Apoptosis”, Biochemical and Biophysical Research Comm., pp. 456-459 (1999), vol. 255.
Beltz et al., “The Effects of Telomerase Inhibitors on Lymphocyte Function”, Anticancer Res. 19: 3205-3211, 1999.
Hayakawa et al., “Isothiazolone Derivatives Selectively Inhibit Telomerase from Human and Rat Cancer Cells in Vitro”, Biochemistry 38: 11501-11507, 1999.
Narisawa et al., “Inhibitory Effects of Ursodeoxycholic Acid on N-Methyl-nitrosourea-Induced Colon Carinogenesis and Colonic Mucosal Telomerase Activity in F344 Rats”, J. Exp. Clin. Cancer Res. 18: 259-266, 1999.
Tabata et al., “Diazaphilonic Acid, a New Azaphilone with Telomerase Inhibitory Activity”, J. Antibiot. 52: 412-414, 1999.
Herbert et al., “Inhibition of human teleomerase in immortal human cells leads to progressive telomere shortening and cell death”, Proced. Natl. Acad. Sci. vol. 96, 14276-14281, Dec. 7, 1999.
Han et al., “Accelerated Assembly of G-Quadruplex Structures by a Small Molecule”, Biochemistry 38: 6981, 1999.
Page et al., “The Cytotoxic Effects of Single-Stranded Telomere Mimics on OMA-BL1 Cells”, Exp. Cell Res. 252: 41, 1999.
Harrison et al., “Human Telomerase Inhibition by Substituted Acridine Derivatives”, Bioorg. Med Chem. Lett. 9: 2463, 1999.
Izbicka et al., “Effects of Cationic Porphyrins as G-Quadruplex Interactive Agents in Human Tumor Cells”, Cancer Res. 59: 639, 1999.
Bednarek et al., “Suppression of cell proliferation and telomerase activity in 4-(hydroxyphenyl)retinamide-treated mammary tumors”, Carcinogenesis, vol. 20, No. 5, pp. 879-883, 1999.
Ogoshi et al., “In Situ Hybridization Analysis of the Expression of Human Telomerase RNA in Normal and Pathologic Conditions of the Skin”, The Journal of Investigative Dermatology, vol. 110, No. 5, May 1998.
Botchkarev et al., “A New Role for Neurotrophin-3 Involvement in the Regulation of Hair Follicle Regression (Catagen)”, American Journal of Pathology, vol. 153, No. 3, Sep. 1998.
Botchkarev et al., “Neurotrophin-3 Involvement in the Regulation of Hair Follicle Morphogenesis”, The Journal of Investigative Dermatology, vol. 111, No. 2, Aug. 1998.
Ichikawa et al., “Glucosylceramide synthase and glycosphingolipid synthesis”, trends in Cell Biology, pp. 198-202, May 1998.
Glukhov et al., “Inhibition of Telomerase Activity of Melanoma Cells in Vitro by Antisense Oligonucleotides”, Biochem. Biophys Res. Comm. 248: 368-371, 1998.
Togashi et al., “Inhibition of Human Telomerase Activity by Alterperylenol”, Oncol. Res. 10: 449-453, 1998.
Perry et al., “1,4- and 2,6-Disubstituted Amidoanthracene-9,10-dione Derivatives as Inhibitors of Human Telomerase”, J. Med. Chem. 41: 41: 3253-3260, 1998.
Fedoroff et al., “NMR-Based Model of a Telomerase-Inhibiting Compound Bound to G-Quadruplex DNA”. American Chemical Society, vol. 37, No. 36, pp. 12367-12374, Sep. 8, 1998.
Wheelhouse et al., “Cationic Porophyrins as Telomerase Inhibitors: the Interaction of Tetra-(N-methyl-4-pyridyl)porphine with Quadruplex DNA”, J. Am. Chem Soc. vol. 120, No. 13, pp. 3261-3262, 1998.
Hoffman et al., “Interleukin-1-β-Induced Inhibition of Hair Growth In Vitro is Mediated by Cyclic AMP”, The Journal of Investigative Dermatology, vol. 108, pp. 40-42, 1997.
Yamakuchi et al., “New Quinolones, ofloxacin and levofloxacin, Inhibit Te

Affiliated with

Also associated with

Rating

Reduction of hair growth does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reduction of hair growth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reduction of hair growth will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4019504